home / stock / adtx / adtx news

ADTX News and Press, ADiTx Therapeutics Inc. From 12/12/23

Stock Information
Company Name: ADiTx Therapeutics Inc.
Stock Symbol: ADTX
Market: NASDAQ
Website: aditxt.com
Menu
ADTX ADTX Quote ADTX Short ADTX News ADTX Articles ADTX Message Board
Get ADTX Alerts

News, Short Squeeze, Breakout and More Instantly...
ADTX - Bio Tuesday- 24/7 Market News Snapshot 12 Dec 2023

2023-12-12 09:59:18 ET DENVER, Colo., Dec. 12, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Aditxt Inc (NASDAQ: ADTX), C4 Therapeutics Inc. (NASDAQ: CCCC), IN8bio Inc. (NASDAQ: INAB), Candel Therapeuti...
ADTX - Today's Top 5 Trades

2023-12-12 09:06:38 ET DENVER, Colo., Dec. 12, 2023 ( www.247marketnews.com )- The following companies are our five favorite trades of the day; Siyata Mobile Inc. (NASDAQ: SYTA), Aditxt Inc (NASDAQ: ADTX), C4 Therapeutics Inc. (NASDAQ: CCCC), IN8bio Inc. (NASDAQ: INAB), Alphabet Inc (NA...

ADTX - Aditxt to acquire women's health company Evofem Biosciences

2023-12-12 08:59:04 ET More on Evofem Biosciences Evofem Biosciences expects to see third consecutive quarter of growth Evofem says no Phexxi generic until 2033 after company amends ANDA Financial information for Evofem Biosciences For further details see: ...

ADTX - Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally

Evofem posted $13.4 million in net sales of Phexxi for the first nine months of 2023; Aditxt looks to accelerate Evofem into the global non-hormonal birth control market valued at $27.7 billion in 2022 and is projected to grow to $52.2 billion by 2031 Aditxt, Inc. ( ...
ADTX - SVFD, ADTX and CHSN among pre-market losers

2023-12-08 08:27:04 ET More on pr-market losers $ stocks. Aditxt appoints Ernie Lee as CEO of its wholly-owned subsidiary, Pearsanta IPO Roundup: WeBuy Global, Maison Solutions and more Seeking Alpha’s Quant Rating on Aditx Therapeutics Historical earn...

ADTX - SEEL, AMPE and MOR among pre-market losers

2023-12-01 08:25:56 ET Losers: Smart for Life ( SMFL ) -38% announces exercise of warrants for $1.5 Million gross proceeds . Ampio Pharmaceuticals ( AMPE ) -34% . Incannex Healthcare ( IXHL ) -34% . Vivos Therapeutics ( VVOS ) -14% . ...

ADTX - Redhill Biopharma, Ampio Pharmaceuticals among healthcare movers

2023-11-30 10:00:02 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble For further details see: Redhill Biopharma, Ampio Pharmaceuticals among healthcare movers
ADTX - OPEN, AMPE and NURO are among pre market gainers

2023-11-30 08:06:09 ET Aditxt ( ADTX ) +66% . Clearmind Medicine ( CMND ) +63% . Ampio Pharmaceuticals  ( AMPE ) +63% . Smart for Life ( SMFL ) +29% . China SXT Pharmaceuticals ( SXTC ) +28% . VinFast Auto  ( VFS ) ...

ADTX - Expected US Company Earnings on Monday, November 13th, 2023

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

ADTX - Expected earnings - Aditxt Inc.

Aditxt Inc. (ADTX) is expected to report $-5.99 for Q3 2023
Previous 10 Next 10